![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 31/138 | (2006.01) |
A61K 31/222 | (2006.01) | ||
A61K 31/4025 | (2006.01) | ||
A61K 31/4178 | (2006.01) | ||
A61K 31/438 | (2006.01) | ||
A61K 31/44 | (2006.01) | ||
A61K 31/4725 | (2006.01) | ||
A61K 9/48 | (2006.01) | ||
A61P 25/00 | (2006.01) | ||
A61P 25/14 | (2006.01) | ||
A61P 25/18 | (2006.01) | ||
A61P 25/24 | (2006.01) | ||
A61P 25/26 | (2006.01) | ||
A61P 25/28 | (2006.01) | ||
A61P 25/30 | (2006.01) | ||
A61K 45/06 | (2006.01) | ||
C12N 15/09 | (2006.01) |
(11) | Patento numeris | 3061821 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 16151747.9 |
Europos patento paraiškos padavimo data | 2010-07-21 | |
(97) | Europos patento paraiškos paskelbimo data | 2016-08-31 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2019-07-10 |
(46) | Apibrėžties vertimo paskelbimo data |
(30) | Numeris | Data | Šalis |
213853 P | 2009-07-22 | US | |
282658 P | 2010-03-15 | US |
(72) |
ELENKO, Eric, US
MILLER, Andrew C., US
MURRAY III, Phillip E., US
|
(73) |
Puretech Health LLC,
501 Boylston Street Suite 6102, Boston, Massachusetts 02116,
US
|
(54) | COMPOSITIONS FOR TREATMENT OF DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION |
COMPOSITIONS FOR TREATMENT OF DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION |